Man, 30, Gets First Dose Of India's Covid Vaccine As Human Trial Begins
A 30-year-old man was on Friday given the first dose of undertrial coronavirus vaccine Covaxin at Delhi's All India Institute Of Medical Sciences (AIIMS). A total of 12 volunteers were called for a number of pre-tests that include blood and nasopharyngeal testing for COVID-19. After results, 10 healthy individuals were selected for the vaccine to be given in phases. After the first dose, a report on their health condition will be submitted to the ethics committee, which will reviewing the entire process.
